References
H. Keberle, K. Hoffmann, andK. Bernhard, Exper.18, 105 (1962).
F. Gross, K. Hoffmann, J. Kebrle, andJ. Tripod, Verh. naturf. Ges. Basel67, 479 (1956).
E. Bütikofer, P. Cottier, P. Imhof, H. Keberle, W. Riess, andK. Schmid, Arch. exp. Path. Pharmak., in print (1962).
H. Keberle, W. Riess, K. Schmid, andK. Hoffmann, Arch. int. Pharmacodyn., in print (1962).
W. Kunz, H. Keller, andH. Mückter, Arzneimittelforsch.8, 426 (1956).
W. J. Doran, Med. Chem.4, 17 (1959) (John Wiley and Sons, Inc., New York).
P. G. Marshall andD. K. Vallance, J. Pharm. Pharmacol.7, 406 (1955).
F. Gross, J. Tripod, andR. Meier, Schweiz. Med. Wschr.85, 305 (1955).
CIBA, Brit. Patent 729453; U.S. Patent 2749346.
J. Redel, J. P. Martinaud, andJ. Roquet, Bull. Soc. chim. France1959, 1641.
P. T. Izzo andS. R. Safir, J. Amer. chem. Soc.81, 4668 (1959).
G. S. Skinner, J. B. Bicking, andJ. R. Lovett, J. org. Chem.24, 1587 (1959).
E. Testa, D.B.P. 1074585.
O. Dalmer, C. Diehl, andH. Pieper, U.S. Pat. 2259925.
C. Barkenbus andP. Panzera, J. org. Chem.20, 237 (1955).
P. C. Butler, J. Amer. pharm. Assoc., Sci. Ed.44, 367 (1955).
G. S. Skinner andJ. W. Biking, U.S. Pat. 2786838.
P. R. Rasanen andG. L. Jenkins, J. Amer. pharm. Assoc., Sci. Ed.,38, 599 (1949).
K. Bernhard, M. Just, A. H. Lutz, andJ. P. Vuilleumier, Helv. chim. Acta40, 436 (1957).
B. Pellmont, A. Studer, andR. Jürgens, Schweiz. med. Wschr.85, 350 (1955).
W. Schallek, A. Kuehn, andD. K. Seppelin, J. Pharmacol. exp. Therap.118, 139 (1956).
O. Pribilla, Arch. Toxicol.18, 1 (1959).
W. J. Close andM. A. Spielman, Med. Chem.5, 38 (1961) (John Wiley and Sons, Inc., New York).
S. L. Goodman, E. A. Swinyard, W. C. Brown, D. O. Schiffman, M. S. Greval andE. L. Bliss, J. Pharmacol. exp. Therap.108, 428 (1953).
V. Ferrari, Il Farmaco, Ed. Pr.,9, 211 (1954).
R. Fusco andS. Rossi, Il Farmaco, Ed. Sci.,10, 619 (1955).
J. Belford andD. D. Bonnycastle, J. Pharmacol. exp. Therap.99, 325 (1950).
P. G. Marshall andD. K. Vallance, J. Pharm. Pharmacol.6, 740 (1954).
F. J. Marshall, J. org. Chem.23, 503 (1958).
G. Spaccarelli andV. von Breitenberg, Rec. Progr. Med.19, 419 (1955).
E. Testa andR. Ettore, Arch. Pharm.290, 532 (1957).
R. Handley andA. S. R. Steward, Lancet1952, I, 742.
E. Testa, L. Fontanella, G. Franco, andL. Marini, Helv. chim. Acta42, 2370 (1959).
G. Maffi, Il Farmaco, Ed. Sci.,14, 176 (1959).
G. Maffi, B. Silvestrini, andG. Bianchi, Il Farmaco, Ed. Sci.,14, 269 (1959).
G. Osterloh andF. Lagler, Arzneimittelforsch.10, 985 (1960).
G. F. Somers, Brit. J. Pharmacol.15, 111 (1960).
M. Fincato, Boll. Soc. Ital. Biol. sper.33, 872 (1957).
W. L. Kuhn andE. F. van Maanen, J. Pharmacol. exp. Therap.134, 60 (1961); Fed. Proc.19, 264 (1960).
R. Greene andH. E. A. Farran, Brit. Med. J.1958, II, 1355.
J. McC. Murdoch andG. D. Campbell, Brit. Med. J.1958, I, 84.
D. M. Burley, Med. World (London)93, 26 (1960).
G. Neuhaus andK. Ibe, Med. Klin.55, 544 (1960).
L. P. DeSouza, Brit. Med. J.1959, II, 635.
R. D. MacKenzie andW. R. McGrath, Proc. Soc. exp. Biol. Med.109, 511 (1962).
R. Beckmann andH. H. Kampe, Arzneimittelforsch.11, 45 (1961).
A. A. Bartholomew, Brit. Med. J.1961, II, 1570.
L. C. F. Clievens, Brit. Med. J.1961, II, 1025.
A. L. Florence, Brit. Med. J.1960, II, 1954.
P. M. Fullerton andM. Kremer, Brit. Med. J.1961, II, 855.
K. W. G. Heathfield, Brit. Med. J.1961, II, 1084.
P. Howe, Brit. Med. J.1961, II, 1084, 1570.
E. V. Kuenssberg, J. A. Simpson, andJ. B. Stanton, Brit. Med. J.1961, I, 291.
D. A. Lillicrap, Brit. Med. J.1962, I, 477.
H. J. Raffauf, Dtsch. med. Wschr.86, 935 (1961).
W. F. Robertson, Brit. Med. J.1962, I, 792.
W. Scheid, H. H. Wieck, A. Stammler, A. Kaldetzky, andE. Gibbels, Dtsch. med. Wschr.86, 938 (1961).
J. Shafar, Brit. Med. J.1961, I, 829.
W. Lenz, Diskussionsbemerkung auf der Herbsttagung der Rheinisch-Westf. Kinderärztevereinigung in Düsseldorf (18. 11. 1961); Dtsch. med. Wschr.86, 2555 (1961); Lancet1962, I, 45, 271.
H. R. Wiedemann, Med. Wschr.12, 816 (1961); Med. Welt37, 1863 (1961).
D. M. Burley, Lencet1962, I, 100, 271.
R. E. Devitt andS. Kenny, Lancet1962, I, 430.
A. W. Ferguson, Lancet1962, I, 691.
C. Gyllenswärd, Svenska Läkar-tidningen59, 731 (1962).
D. J. Hayman, Brit. Med. J.1961, II, 1716; Lancet1961, I, 46, 1262.
O. Hepp, Med. Klin.1962, 419.
E. E. Jones andD. A. J. Williamson, Lancet1962, I, 222.
H. S. Kohler, A. M. Fisher, andP. M. Dunn, Lancet1962, I, 326.
The Editors of the Lancet,1961, II, 753;1962, I, 307.
W. G. McBride, Lancet1961, II, 1358.
B. C. Morgan, Brit. Med. J.1962, I, 792.
C. E. Petersen, Medizin. Welt1962, 753.
R. A. Pfeiffer andW. Kosenow, Münch. med. Wschr.104, 68 (1962); Lancet1962, I, 45.
G. Rogerson, Lancet1962, I, 691.
C. Scott Russell andM. D. McKichan, Lancet1962, I, 429.
F. Stabler, Lancet1962, I, 591.
G. F. Somers, Lancet1962, I, 912.
A. L. Speirs, Lancet1962, I, 303.
R. W. Smithells,Lancet 1962, I, 591, 1270.
G. I. Watson, B. C. S. Slater, andJ. C. McDonald, Brit. Med. J.1962, I, 793.
H. Weicker andH. Hungerland, Dtsch. med. Wschr.87, 992 (1962).
A. Willman andJ. G. Dumoulin, Brit. Med. J.1962, I, 477.
F. E. King, B. S. Jackson, andD. A. A. Kidd, J. chem. Soc. (London)1951, 243.
E. Sondheimer andR. W. Holley, J. Amer. chem. Soc.79, 3767 (1957);76, 2467 (1954).
W. Block andJ. Ebigt, Arzneimittelforsch.10, 709 (1960).
V. Klingmüller,Biochemie, Physiologie und Klinik der Glutaminsäure (Verl. Edition Cantor Kg./Anlendorf in Württ. 1955).
R. L. M. Synge, Biochem. J.48, 429 (1950).
H. Weil-Malherbe, Physiol. Rev.30, 549 (1950).
H. Weil-Malherbe, Biochem. Soc. Symposia8, 16 (1952).
H. Waelsch, Naturwiss.40, 404 (1953).
H. Weil-Malherbe, Naturwiss.40, 541 (1953);41, 124 (1954).
F. Kemper, Z. ges. exp. Med.135, 454 (1962).
L. Jaenicke, Angew. Chemie73, 449 (1961).
H. Tewes, Münch. med. Wschr.104, 269 (1962).
M. L. Murphy, C. P. Dagg, andD. A. Karnofsky, Pediatrics19, 701 (1957).
J. M. Leck andE. L. M. Millar, Brit. Med. J.1962, II, 16.
E. Abderhalden andE. Tetzner, Z. physiol. Chem.232, 79 (1935).
W. H. Fishman andC. Artom, Proc. Soc. exp. Biol. Med.57, 241 (1944).
J. G. Wilson, J. chron. Dis.10, 111 (1959).
H. Kalter andJ. Warkany, Physiol. Rev.39, 69 (1959).
F. C. Fraser, J. chron. Dis.10, 97 (1959).
R. McIntosh, J. chron. Dis.10, 139 (1959).
H. Jackson, Pharmacol. Rev.11, 135 (1959).
J. Warkany, J. chron. Dis.10, 84 (1959).
A. Giroud, Biol. Med.44, 1 (1955).
P. Gruenwald, Arch. Path.44, 398 (1947).
G. E. W. Wolstenholme andC. M. O'Connor (Editors), Ciba Foundation Symposium on Congenital Malformations (J. and A. Churchill Ltd., London 1960).
Ciba Foundation Symposium on Amino Acids and Peptides with Antimetabolic Activity (J. and A. Churchill Ltd., London 1958).
Author information
Authors and Affiliations
Additional information
Generic name for the hypnotic known as Contergan® (Chemie Grünenthal AG.).
Rights and permissions
About this article
Cite this article
Faigle, J.W., Keberle, H., Riess, W. et al. The metabolic fate of thalidomide. Experientia 18, 389–397 (1962). https://doi.org/10.1007/BF02151479
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02151479